Dataset Information

Characterization of the Human Intestinal Calcium Transporter, CaT1, Stably Expressed in CHO Cells.

ABSTRACT: The human calcium transporter, hCaT1, was cloned and analyzed. The obtained amino acid sequence was slightly different from the ortholog of hCaT1 which had been identified by Peng et al. (2000. Biochem. Biophys. Res. Commun 278: 326-332). An mRNA analysis of human gastrointestinal segments demonstrates that hCaT1 was expressed in the stomach, duodenum, jejunum, ileum, ileocecum, cecum, ascending colon, transverse colon, descending colon, and, at very low levels, in the esophagus and rectum. hCaT1 was transiently expressed by transfecting COS-1 cells and was stably expressed by the transfected CHO cells. The transfected cells expressed hCaT1 with a molecular mass of 75 kDa. Stable expression of hCaT1 in the CHO cells increased the cellular uptake of Ca(2+). hCaT1 was inhibited by La(3+), Gd(3+) and Cd(2+), whereas Co(2+), Fe(2+), Mn(2+) and Mg(2+) showed no significant effects on the activity. Acidification of the extracellular solution to pH 5.5 reduced the (45)Ca(2+)uptake by hCaT1 in the CHO cells. The addition of lactose and raffinose had no effect on the (45)Ca(2+) uptake, whereas galactose and glucose increased the (45)Ca(2+) uptake. CHO cells stably expressing hCaT1 will be useful to detect and analyze food substances that could modulate the hCaT1 activity.

SUBMITTER: Takano Y

PROVIDER: S-EPMC3449598 | biostudies-other | 2003 Nov

REPOSITORIES: biostudies-other

ACCESS DATA

Publications

Characterization of the Human Intestinal Calcium Transporter, CaT1, Stably Expressed in CHO Cells.

Takano Yoshihiko Y Sato Ryuichiro R Satsu Hideo H Shimizu Makoto M

Cytotechnology 20031101 1-3

The human calcium transporter, hCaT1, was cloned and analyzed. The obtained amino acid sequence was slightly different from the ortholog of hCaT1 which had been identified by Peng et al. (2000. Biochem. Biophys. Res. Commun 278: 326-332). An mRNA analysis of human gastrointestinal segments demonstrates that hCaT1 was expressed in the stomach, duodenum, jejunum, ileum, ileocecum, cecum, ascending colon, transverse colon, descending colon, and, at very low levels, in the esophagus and rectum. hCaT ...[more]

PMID: 19003215

Similar Datasets

Project description:BACKGROUND:The R-Spondin proteins comprise a family of secreted proteins, known for their important roles in cell proliferation, differentiation and death, by inducing the Wnt pathway. Several studies have demonstrated the importance of RSPOs in regulation of a number of tissue-specific processes, namely: bone formation, skeletal muscle tissue development, proliferation of pancreatic β-cells and intestinal stem cells and even cancer. RSPO1 stands out among RSPOs molecules with respect to its potential therapeutic use, especially in the Regenerative Medicine field, due to its mitogenic activity in stem cells. Here, we generated a recombinant human RSPO1 (rhRSPO1) using the HEK293 cell line, obtaining a purified, characterized and biologically active protein product to be used in Cell Therapy. The hRSPO1 coding sequence was synthesized and subcloned into a mammalian cell expression vector. HEK293 cells were stably co-transfected with the recombinant expression vector containing the hRSPO1 coding sequence and a hygromycin resistance plasmid, selected for hygror and subjected to cell clones isolation. RESULTS:rhRSPO1 was obtained, in the absence of serum, from culture supernatants of transfected HEK293 cells and purified using a novel purification strategy, involving two sequential chromatographic steps, namely: heparin affinity chromatography, followed by a molecular exclusion chromatography, designed to yield a high purity product. The purified protein was characterized by Western blotting, mass spectrometry and in vitro (C2C12 cells) and in vivo (BALB/c mice) biological activity assays, confirming the structural integrity and biological efficacy of this human cell expression system. Furthermore, rhRSPO1 glycosylation analysis allowed us to describe, for the first time, the glycan composition of this oligosaccharide chain, confirming the presence of an N-glycosylation in residue Asn137 of the polypeptide chain, as previously described. In addition, this analysis revealing the presence of glycan structures such as terminal sialic acid, N-acetylglucosamine and/or galactose. CONCLUSION:Therefore, a stable platform for the production and purification of recombinant hRSPO1 from HEK293 cells was generated, leading to the production of a purified, fully characterized and biologically active protein product to be applied in Tissue Engineering.

Project description:Lactoferrin (LF), an iron binding protein with immune modulatory activities, has adjuvant activity to enhance vaccine efficacy. Tuberculosis (TB) is a pulmonary disease caused by the pathogen Mycobacterium tuberculosis (MTB). Progressive TB disease is clinically defined by damaging pulmonary pathology, a result of inflammation due to immune reactivity. The current vaccine for TB, an attenuated strain of Mycobacterium bovis, Bacillus Calmette Guerin (BCG), has only limited efficacy to prevent adult pulmonary TB. This study examines a Chinese hamster ovary (CHO) expressed recombinant human LF (rHLF) to boost efficacy of the BCG vaccine and delay early pathology post infectious challenge. C57BL/6 mice were immunized with BCG, or BCG admixed with either rHLF or bovine LF (bLF; internal control), or remained unvaccinated. Mice were then aerosol challenged with Erdman MTB. All vaccinated mice demonstrated decreased organ bacterial load up to 19 weeks post infection compared with non-vaccinated controls. Furthermore, mice receiving bLF or rHLF supplemented BCG vaccines showed a modest decrease in lung pathology developed over time, compared to the BCG vaccine alone. While mice vaccinated with BCG/rHLF demonstrated increased general lung inflammation at day 7, it occurred without noticeable increase in pro-inflammatory cytokines. At later times, decreased pathology in the rHLF groups correlated with decreased inflammatory cytokines. Splenic recall to BCG antigens showed BCG/rHLF vaccination increased production of IFN-?, IL-6, and GM-CSF compared to naïve, BCG, and BCG/bLF groups. Analysis of T cell stimulating functions of bone marrow derived macrophages and dendritic cells treated with BCG/bLF or BCG/rHLF showed decreases in IL-10 production when co-cultured with sensitized CD4 and CD8 T cells, compared to those cultured with macrophages/dendritic cells treated with BCG without LF. These results indicate that addition of rHLF to the BCG vaccine can modulate development of host pathology early post infectious challenge, most likely through host immune regulation affecting hypersensitive responses.

Dataset Information

Characterization of the Human Intestinal Calcium Transporter, CaT1, Stably Expressed in CHO Cells.

Publications

Characterization of the Human Intestinal Calcium Transporter, CaT1, Stably Expressed in CHO Cells.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets